Environmental, Social And Governance Report

Overview

The report presents JW Therapeutics' 2023 ESG performance across governance, environmental and social topics. It reports 33% female directors and Board-level ESG responsibility, alongside 399 full-time employees with 100% training coverage and an average of 23 training hours per employee. Environmental disclosures include 10,907.97 MWh total energy consumption, 88.40 tCO 2 e Scope 1 emissions and 4,883.06 tCO 2 e Scope 2 emissions, with a 40% intensity-reduction target by 2025. The report also highlights patient access through Carteyva listings in more than 70 commercial insurance products and 105 local governmental complementary medical insurance programs.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2023
Period: 1 January 2023 – 31 December 2023
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services

Overview